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Introduction
Striae distensae (alba) is a relatively common skin 
disorder. It manifests as linear dermal atrophic scars and 
can cause significant distress to the affected individuals.1-4 
Striae distensae involves the skin which is susceptible 
to constant and dynamic stretching. Enlargement of the 
different parts of the body imposes progressive stress 
and stretch on the connective tissue. They often emerge 
on different parts of athletes’ body, on the breasts and 
abdomen of pregnant women, in teenagers during the 
peak of their growth, and in over weighted people.5-8
Etiologic factors of striae have not been completely 
revealed. Skin stretch may result in explosive 
degranulation of mast cells with consequent destruction 
of elastin and collagen fibers.9 Cushing syndrome or long 
term administration of topical/oral corticosteroids may 
cause the developing of striae.5,10-13 Genetic susceptibility 
can definitely have a major role as well; however, the 
precise mechanism has not completely elucidated. Tung 
et al performed some accurate genome analysis and 
demonstrated the collapse of elastic microfibrils as the 
etiology of some cases of striae distensae.14 
Currently, even with the major progresses in topical 
medications and invention of different therapeutic devices, 
complete treatment of these skin lesions has remained an 
unachievable target.15 Development of stretch marks may 
be prevented by avoidance of brisk weight gain or loss; 
particularly in high-risk groups e.g. adolescents, athletes, 
and pregnant women.16 Application of topical retinols, 
fruit acids, vitamin C, and other medicaments have been 
recommended for the treatment of striae rubra in its early 
stages, but all have moderate efficacy.17,18 Topical tretinoin 
improve the appearance of striae rubra significantly19-22; 
however, it is contraindicated in breastfeeding or pregnant 
women due to its probable teratogenic side effects.23,24
Several studies have reported the improvement of the 
clinical appearance of striae with 585-nm pulsed dye 
laser (PDL) via enhancement of the extracellular matrix 
collagen.25-28 In addition, it has a modest efficacy in 
decreasing the erythema of striae rubra; however, it has 
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no obvious advantage in striae alba.29-32 More recently, 
there has been evidence that indicates the benefits of both 
fractionated non-ablative and ablative lasers in increasing 
collagen fibers, and improving the appearance of striae 
alba. Our study aimed to assess the effectiveness a 
fractionated CO2 in the treatment of striae alba, especially 
in darker skin types. 
Patients and Methods
In a prospective clinical trial, 30 patients with striae 
alba who were referred to our dermatology clinic were 
included in the study. The inclusion criteria consisted of 
striae for at least 1 year, skin type III to V, and informed 
consent to attend the study. The exclusion criteria 
included pregnancy or breast feeding, history of using 
immunosuppressive drugs, history of keloid formation, 
any treatment of striae in the last 6 months, and history 
of collagen or elastin disorders. Baseline characteristics 
(gender, age) and medical history (etiology of striae, 
skin type, and location of striae) were collected from 
the recorded hospital files. Photography was initially 
performed using canon SX-200 camera from standardized 
anterior position for each patient. Two photographs were 
taken of the straie of each patient, including one from the 
far view and another from up close view at baseline and 
also at the end of study period. 
At baseline, cutaneous resonance running time (CRRT) 
was measured by a reviscometer (multi-  probe adaptor 
system MPA5). This assessment was repeated at week 4 
and 3 months after the last session of laser therapy. Prior 
to the treatment, local anesthesia was applied with a 2% 
lidocaine cream for 30 minutes. The lidocaine cream 
was wiped off, and the patients were treated with the 
fractionated 10600 nm CO2 laser (Ultra Pulse, Lumenis 
Ltd, Yokneam, Israel) at the following settings: Deep Fx:2, 
intensity:10 J/cm², spot size: 12, and 2 passes. After the 
treatment, zinc oxide cream was applied to the treated 
areas. Each patient received 2 treatment sessions with 
4-week intervals.
Patients were then followed-up for 3 months after the 
last treatment, and skin elasticity was measured again. 
Any side effects including erythema, burns, keloids and 
hyperpigmentation were recorded and scored as mild, 
moderate and severe. The appearance of any unintended 
complication was considered as a criterion for excluding. 
The level of improvement was assessed by 2 independent 
dermatologists by comparing photographs taken 3 
months after the last treatment with baseline photographs. 
The level of patient satisfaction was also categorized as 
unchanged, good, moderate, excellent, and very excellent 
in each session and after 3 months of treatment.
All data analyses were performed using the statistical 
software SPSS 16.0.0. (SPSS Inc. Chicago, IL, USA). 
P values less than 0.05 were considered statistically 
significant. All tests were 2-sided. Continuous variables 
were reported as mean ± standard deviation (SD) or as 







Mean ± SD 33.63±8.26




Cause of striae alba
Weight change 16 (53.3)
Pregnancy 13 (43.3)
Corticosteroid use 1 (3.3)
Data are expressed as no. (%) unless otherwise stated.
medians with total and inter quartile ranges (25th-75th 
percentiles). Categorical data were summarized as number 
(percentage). The normality of continuous variables was 
assessed using the Shapiro-Wilk’s W-test. Friedman test 
was used to evaluate the differences in CRRT values. 
For pair-wise comparisons, Wilcoxon signed-rank 
tests with Bonferroni corrections were conducted. 
 
Results
Thirty patients with striae alba (27 females and 3 males) 
were included in this study. Baseline demographics and 
clinical characteristics of the patients are summarized in 
Table 1.
Three months after the last treatment, 5 of the 30 
participants (16.7%) had moderate improvement, 19 
(63.3%) had minimal improvement, and 6 (20%) had 
no improvement (Figure 1). None of the participants 
showed worsening of their striae alba during the course 
of study. Evaluation of overall participant satisfaction 
3 months after the treatment revealed that 3 of the 30 
participants (10%) were very satisfied, 3 (10%) were 
satisfied, one (3.3%) was slightly satisfied, and 21 (76.7%) 
were unsatisfied.
A statistical significant difference was detected in median 
CRRT levels during the study (P < 0.0001, Friedman 
test). The median CRRT levels were significantly higher 
in fourth week and 3 months after the last treatment 
compared to the baseline (both P < 0.001, Wilcoxon 
signed-rank test). Furthermore, a significant increase was 
observed in median CRRT level from week 4 till the end 
of study (P < 0.001, Wilcoxon signed-rank test).
After the first laser session, mild-to-moderate post-
treatment erythema was detected in approximately 
half of the patients and resolved during 2–10 days after 
treatment.
Also, post-therapy erythema was observed in 8 patients 
(26.6%) after the second sessions of laser therapy, which 
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disappeared within 1 week. Adverse events such as burns 
and post-inflammatory hyperpigmentation (PIH) were 
observed in 5 patients (17%) after the first session of 
laser therapy and resolved within 2 weeks. Additionally, 




As previously described, laser treatments are now the 
most effective techniques for treating striae alba. Since 
the appearance of striae alba is the last stage of striae, 
response to various treatments is not ideal. In this regard, 
different laser-based treatments were tested in treating this 
condition, but the impact of laser fractional CO2 (10 600 
nm) therapy was not assessed previously in darker skin 
patients. In this context, our study showed that almost 
two-thirds of treated patients had a mild response within 
3 months of treatment, while 46.7% had a moderate 
response and 20% suffered from unchanged clinical 
condition. In addition, within the first 4 weeks, only 40% 
experienced mild response. Although adverse effects were 
reported in patients, these complications were all mild 
and self-limited. Regarding patients’ satisfaction, only 
20% had partial or complete satisfaction of the treatment 
method. 
In previous studies, different response levels were 
achieved. In a study by 
Naein and Soghrati, fractional photothermolysis with 
a fractional CO2 laser for treatment of striae alba was 
more effective than conventional local methods.33 
In another study by Yang and Lee, both nonablative 
fractional and ablative CO2 fractional lasers showed 
significant clinical and histopathologic improvement of 
striae when compared to the pretreatment area; however, 
both treatments did not statistically differ.34 Alexiades-
Armenakas et al also indicated that following treatment 
with the 308-nm excimer laser, the percentage of pigment 
correction increased in direct correlation with the 
number of treatment sessions.35 In a recent study, Wang 
et al compared the safety and efficacy of a 1540-nm 
Figure 1. Steria Alba on the Arm (A) at Baseline and (B) 3 months 
After the Last Treatment by Fractional CO2 Laser (2 sessions) With 
4-Week Interval.
and 1410-nm non- ablative fractional laser in treatment 
of striae, histologically and clinically. Both methods 
resulted in clinical and histological improvement. 
However, no significant difference was observed between 
these lasers.36 In another study by Ostovari et al, the 
mexameter-based data analysis showed that the excimer 
laser had poor efficacy in the repigmentation of the striae 
lesions.37 Malekzad et al similarly reported poor results 
after 8 sessions of treatment with 1540-nm non-ablative 
fractional laser.38 
In this study, the 3 months follow up photos demonstrated 
80% of patients had a poor or moderate improvement. It 
is possible that further treatment sessions are required 
to achieve considerable improvement. In particular it 
seems that concomitant laser fractional CO2 10600 nm 
treatment with additional topical treatments and other 
lasers may enhance the improvement rate. Moreover, 
striae alba continues to be a challenging condition to treat 
despite great advances in laser surgery. 
Conclusion
Striae alba remain a challenging condition to treat. 
The treatment of striae alba with CO2 fractional laser 
results in minimal improvement with mild side effects. 
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